Most Recent Articles by Sara Gianella Weibel, MD
The stability of the latent HIV-1 reservoir presents a challenge to virus eradication. A recent study focuses on examining this mechanism in viral persistence.
Tenofovir gel reduced the incidence of HIV infection by 61% in women with Lactobacillus-dominant vaginal flora but only 18% in women with non-Lactobacillus bacteria, according to a new study.
Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.
Dr Sara Gianella Weibel talks with Jeff Taylor, community activist and long-term HIV survivor, about a new end-of-life model to study HIV persistence.
Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.
More Articles by Sara Gianella Weibel, MD
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Guideline Update: Influenza Immunization Recommendations for 2017-2018
- Update on Pediatric HCV: Screening, Treatment, and Other Considerations
- Time to Sputum Culture Conversion Similar in Isoniazid-Resistant and Susceptible TB
- HPV Vaccine Does Not Increase Risk for Adverse Maternal, Infant Outcomes
- DAAs Effective for HCV in Patients With Thalassemia
- Mycoplasma genitalium: Challenges in Diagnosis and Treatment
- FDA: Vabomere Approved for Complicated UTI Following Priority Review
- Update on Safe, Effective Treatments for Latent Tuberculosis Infection
- New CDC Guidelines for SSI Prevention Leave Unanswered Questions
- Influenza Vaccination During Pregnancy Reduces Infant Risk for Acute Lower Respiratory Infection